| SGS N | 2,646.00 / +0.15% |
| Date/Time | 03/02 / 17:30 |
| Chg. / Chg.(%) | 4.00 / +0.15% |
| Bid | - / 20 |
| Ask | 2,665.00 / 22 |
| Open | 2,654.00 |
| Previous Close | 2,642.00 |
| High | 2,656.00 |
| Low | 2,629.00 |
| Volume [CHF] | 39,956,573.50 |
| Volume [Units] | 15,112 |
| Price fixings | 2289 |
| ISIN | CH0002497458 |
| Security | SGSN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
| Bid Size | Bid | Ask | Ask size |
|---|---|---|---|
| 20 | - | 2,665.00 | 22 |
| 1 | 2,628.00 | 2,680.00 | 7 |
| 18 | 2,610.00 | 2,690.00 | 10 |
| 10 | 2,601.00 | 2,750.00 | 118 |
| 10 | 2,600.00 | 2,770.00 | 20 |
| 11 | 2,595.00 | 2,780.00 | 7 |
| 10 | 2,591.00 | 2,782.00 | 2 |
| 10 | 2,590.00 | 2,787.00 | 9 |
| 10 | 2,586.00 | 2,790.00 | 15 |
| 10 | 2,581.00 | 2,800.00 | 219 |
News
- Viscount Mining Commences 2021 Field Season at Silver Cliff, Colorado
02/25/2021 / 14:45 - Newsfile Corp - Positive Results from Metallurgical Test Work at the Buckreef Gold Project
02/25/2021 / 12:55 - GlobeNewswire - Gran Colombia Gold Provides Exploration Update for Its Segovia Operations
02/23/2021 / 13:00 - GlobeNewswire - GoviEx Updates Madaouela Project Pre-feasibility Study Start-up Capital and Operating Costs Reduced
02/18/2021 / 13:00 - Newsfile Corp - Selecta Biosciences and AskBio Initiate First-in-Human Dose-Escalation Study to Evaluate ImmTOR™ in Gene Therapy
02/17/2021 / 14:00 - GlobeNewswire
Real-time